ARQT David Joseph Topper sold Arcutis Biotherapeutics, Inc. shares — SEC Form 4SELLArcutis Biotherapeutics, Inc.

David Joseph Topper, Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 9,600 shares at $15.80 ($152K) on 2025-04-02, disclosed to the SEC on 2025-04-03.

SEC EDGAR Filing

0001787306-25-000053

View on SEC EDGAR

Trade context

Scheduled sale ($152k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.

Modest55/100

Nothing distinguishes this filing.

Opportunistic Sell

Trade Context

•Decreased holdings by 5%
•Largest sale ever, out of 2
•Last sale was 190 days ago
•Selling near 52-week high (-4% from peak)
•4 other insiders also sold in last 30 days
+3 more

Filing Info

Filed2025-04-03

Traded2025-04-02

Accession0001787306-25-000053

SourceSEC EDGAR (Historical)

Insider

NameDavid Joseph Topper

TitleChief Financial Officer

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
ARQT	SELL	2024-09-25	$220K	—	Filing →

Get an email when an insider at ARQT files

Free account. Follow ARQT and up to 10 more companies.

Follow ARQT for free

ARQT David Joseph Topper sold Arcutis Biotherapeutics, Inc. shares — SEC Form 4SELLArcutis Biotherapeutics, Inc.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes